This study will compare the effectiveness of an upright magnetic resonance imaging () compared to specific antigen () and current imaging for cancer screening.

This Study is Open To:

Men 18 years and older who:

Are at risk of cancer and have been told to have a MRI
Can undergo all parts of the study including guided biopsy
Can tolerate general or spinal anesthesia
Ability to understand and the willingness to sign a written informed consent and to comply with the protocol.

This Study is NOT Open To:

Those who do not meet the criteria defined above and individuals who:

Have been treated with 5-alpha-reductase inhibitors (marketed as Proscar, Propecia, or Avoadart) within 6 months before beginning the study
Have had a previous biopsy, surgery, or treatment for cancer
Have a urinary tract infection or history of acute prostatitis, inflammation of the , within the last 3 months
Cannot have an

What the Study Involves

Participants will have a standard of care as well as an upright, seated . After each , participants will be asked to fill out questionnaires to assess their comfort level during the scans. If something suspicious is found on either scan, participants may have an guided biopsy of the , a way to sample and test tissue for cancer. Researchers will check in with the participants every 6 months for 5 years.

Lead Researcher

Ash Tewari: Icahn School of Medicine at Mount Sinai

Study Contact Information:

For additional information, please contact:

Study Director: Dara Lundon (212) 241-0751 Dara.Lundon@mountsinai.org

Locations:

New York

New York

City: New York RECRUITING
Facility: Icahn School of Medicine at Mount Sinai
Contact Info:
Dara.Lundon@mountsinai.org (212) 241-0751 Dara Lundon

Prevention

Study Contact Information:

Upright MRI for Prostate Cancer Screening

Prevention

Study Contact Information:

About the Study

This Study is Open To:

This Study is NOT Open To:

What the Study Involves

Lead Researcher

Study Contact Information:

Locations:

New York

Knowledge Can Save Lives